Kieran John Email and Phone Number

Firstlight Pharmaceuticals is pioneering a novel scientific framework to modulate specific G-Protein Coupled Receptors. These proteins play key roles in the progression of a variety of oncolytic, neurologic, and endocrine diseases. Disease progression results when normal cellular regulation is not achieved. Our unique approach restores that equilibrium. As the founder of an early-stage biotech venture, I’ve leveraged my deep expertise to bridge established and emerging science, developing innovative approaches in drug discovery. I’ve worked closely with medicinal chemists, biologists, and patent attorneys while navigating the complexities of early-stage financing and intellectual property strategy. My entrepreneurial journey is driven by self-motivation, balancing cutting-edge research with practical business realities. With global thought leadership connections, I’ve crafted a patent strategy spanning multiple jurisdictions, positioning Firstlight at the forefront of therapeutic innovation.

Independant consultant to the pharmaceutical industry.

Time off is just as important as time on. After years of being single-mindedly focused on my career, I intentionally left the corporate world to travel with my children, and spend time with family before embarking on my next adventure. We explored Europe, spent time with aging parents in Asia, and road-tripped across the U.S. During this time, I discovered a new passion for cooking— funnily enough, somewhat reminiscent of my early days as a bench scientist. I also stayed engaged by volunteering on the Leadership Committee of the American Cancer Society of South Jersey & Philadelphia, and serving as Chair of my municipality's Environmental Commission, maintaining my leadership and community involvement.

Assist the Chief Commercial Officer, Chief Strategy Officer and be Chief of Staff of the Worldwide Commercial Leadership Team. • Responsible for a team of eight direct reports to partner effectively across the organization to deliver dynamic short- and long- term strategic and functional brand plans to achieve the future potential of the company’s early assets and indications in a way that optimizes speed to market, competitiveness and commercial success. • Prepare commercial updates for senior executives at major internal company meetings, updates to the BMS Board of Directors, and presentations to external investor community.• Lead global commercial business continuity plans, global tracking of current and future launches and to play a leadership role in numerous initiatives that deliver simplification, employee engagement, and transformation across the commercial organization.

Led country commercial teams to develop and execute an integrated worldwide commercial strategy to ensure organizational support and resourcing to maximize commercial success in therapeutic areas of HIV, Hepatitis B and renal transplantation. • Built a burning platform to champion to the company senior executives an established brands strategy that ensured commercial readiness to meet global LCM timelines and local market opportunities. • Coordinated the commercial launch of a major line extension within the HIV portfolio, identifying centralized vs. local activities, setting pricing guidelines, and assessing impact of pricing and market access scenarios.

Responsible for leading the commercial planning and execution of a companion diagnostic and biomarker strategy for OPDIVO.Accountability for the global strategic planning of the PD-L1 companion diagnostic, including Go To Market transition. In addition to CDx launch strategy and planning, was responsible for the overall brand budget, as well as brand labeling work including biomarker and cross tumor integration. Partnership with Tumor Indication Leads, Global Functional Leads (Market Access, Market Research, GMHQ, CDx development team), US, European, and Intercon Brand Leads to refine and execute a well coordinated CDx strategy for OPDIVO. Co-led the CDx Joint Commercialization Committee with CDx partner.

As the Pan Tumor Commercial Lead, responsible for creating OPDIVO’s brand identity (the brand name, brand colors, brand logo, clinical trial branding), global positioning platform, creative campaign, branded and unbranded secondary graphics, branded and unbranded patient education brochures, safety and adverse events management guide, graphics and description of the mechanism of pathway (MOP), mechanism of action/MOP brochure, and development of the global brand book. Company congress lead for ASCO and for developing specific commercial strategy for Anti-PD-1 in China.

As the Commercial Lung Lead for OPDIVO (2010 – 2012), established and refined the company’s tumor strategy, target product profiles and key label claims to optimize commercial success. Closely collaborated with the lung clinical and development teams, medical leads, market research, market access and HEOR, country market leads and academic thought leaders to develop key insights to inform and execute the OPDIVO lung strategy across the rapidly evolving treatment paradigm.

Responsible for driving global launch commercialization of a Phase 2 Non-Small Cell Lung Cancer product globally including market shaping, sizing and product positioning. Helping to lead the lung cancer tumor strategy group

Reporting to Virology Disease Area Lead. Responsible for leading all market expansion strategies for Baraclude across BMS footprint in Asia, including China, India, Taiwan, Hong Kong, Malaysia, Singapore, Indonesia and also Australia. Developed strategies and tactics that included regional/market websites and branded tactics and disease awareness tactics.

Reporting to VP of ASEAN Markets, assisted GMs to manage P&L roll up of ASEAN markets including Taiwan, Hong Kong, Malaysia, Singapore, Indonesia, Pakistan. Responsible for mature products rationalization and geographic footprint realignment across Asia.

Reporting to Director of Professional Promotions. Responsible for professional marketing for stroke indication and later responsible for promotional medical education efforts across all indications. Led POA activities and multiple interactions with sales team in order to develop and execute tactics. Compliance and legal point.